“The whole subtlety, I would even say the beauty of our profession, is to get rid of the disease while affecting the patient as little as possible,” says Doctor Manuel Rodrigues, oncologist at the Institut Curie and vice-president of the French Cancer Society. “This is a major challenge in clinical research today: personalizing treatment and adapting it to the aggressiveness of the disease to improve patient care in all its dimensions, physical, psychological and social. »
This article is reserved for subscribers
Would you like to read more? Subscribe without obligation to our digital offer
I subscribe
